Edoardo Spina
Impact in
- Psychiatry and Mental health top 0.1%
- Schizophrenia research and treatment
- Epilepsy research and treatment
- Bipolar Disorder and Treatment
- Electroconvulsive Therapy Studies
- Pharmacology top 0.05%
- Pharmacogenetics and Drug Metabolism
- Treatment of Major Depression
Papers in
-
- Schizophrenia research and treatment 82
- Epilepsy research and treatment 55
- Bipolar Disorder and Treatment 45
- Electroconvulsive Therapy Studies 27
- Pharmacology 47
- Treatment of Major Depression 52
- Pharmacogenetics and Drug Metabolism 42
- Co-authors
- José de LeónEmilio PeruccaMaria Gabriella ScordoAngela AvenosoGianluca TrifiròConcetta D’ArrigoVincenza SantoroAchille P. Caputi
- Journals
- Therapeutic Drug Monitoring (28 papers)Expert Opinion on Drug Metabolism & Toxicology (13 papers)European Journal of Clinical Pharmacology (11 papers)Pharmacological Research (10 papers)Frontiers in Pharmacology (8 papers)
- Partner nations
- ItalyUnited StatesSweden
In The Last Decade
Edoardo Spina
271 papers receiving 9.5k citations
Peers
Comparison fields: 5 of 152
- Psychiatry and Mental health 5.0k
- Pharmacology 2.5k
- Biological Psychiatry 569
- Toxicology 474
- Pharmacology 2.0k
Countries citing papers authored by Edoardo Spina
This map shows the geographic impact of Edoardo Spina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edoardo Spina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edoardo Spina more than expected).
Fields of papers citing papers by Edoardo Spina
This network shows the impact of papers produced by Edoardo Spina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edoardo Spina. The network helps show where Edoardo Spina may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Edoardo Spina, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 10 | |
| 5 | 2024 | 5 | |
| 6 | 2024 | 2 | |
| 7 | 2023 | 1 | |
| 8 | 2021 | 19 | |
| 9 | 2021 | 16 | |
| 10 | 2021 | 32 | |
| 11 | 2018 | 136 | |
| 12 | 2016 | 29 | |
| 13 | 2016 | 23 | |
| 14 | 2014 | 14 | |
| 15 | Generic antidepressant drugs: a reappraisal | 2013 | 1 |
| 16 | 2012 | 76 | |
| 17 | 2008 | 22 | |
| 18 | 2004 | 27 | |
| 19 | 2003 | 49 | |
| 20 | 2000 | 140 |
About Edoardo Spina
Edoardo Spina is a scholar working on Psychiatry and Mental health, Pharmacology, Biological Psychiatry, Toxicology and Pharmacology, having authored 273 papers that have together received 9.9k indexed citations. Recurring topics across this work include Schizophrenia research and treatment (82 papers), Epilepsy research and treatment (55 papers), Treatment of Major Depression (52 papers), Pharmacological Effects and Toxicity Studies (48 papers), Bipolar Disorder and Treatment (45 papers), Pharmacogenetics and Drug Metabolism (42 papers), Electroconvulsive Therapy Studies (27 papers) and Pharmaceutical studies and practices (23 papers). The work is most often cited by research in Psychiatry and Mental health (5.0k citations), Pharmacology (2.5k citations), Biological Psychiatry (569 citations), Toxicology (474 citations) and Pharmacology (2.0k citations). Edoardo Spina has collaborated with scholars based in Italy, United States and Sweden. Frequent co-authors include José de León, Emilio Perucca, Maria Gabriella Scordo, Angela Avenoso, Gianluca Trifirò, Concetta D’Arrigo, Vincenza Santoro, Achille P. Caputi, Marja‐Liisa Dahl and Gabriella Facciolà. Their work appears in journals such as Therapeutic Drug Monitoring, Expert Opinion on Drug Metabolism & Toxicology, European Journal of Clinical Pharmacology, Pharmacological Research and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.